Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study (vol 38, pg 2990, 2021)

被引：0

作者：

Ansari, Ejaz ^{[1
]}

Pavicic-Astalos, Jasna ^{[2
]}

Ayan, Filis ^{[3
]}

King, Anthony J. ^{[4
]}

Kinsella, Matthew ^{[5
]}

Ng, Eugene ^{[2
]}

Nita, Anca ^{[6
]}

机构：

[1] Univ Kent, Maidstone & Tunbridge Wells NHS Trust, Canterbury, Kent, England

[2] UPMC Whitfield, Inst Eye Surg, Waterford, Ireland

[3] Santen UK Ltd, St Albans, England

[4] Nottingham Univ Hosp NHS Trust, Nottingham, England

[5] Stoke Mandeville Hosp, Buckinghamshire Healthcare NHS Trust, Aylesbury, Bucks, England

[6] Royal Victoria Infirm, Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England

来源：

ADVANCES IN THERAPY | 2022年 / 39卷 / 01期

关键词：

D O I：

10.1007/s12325-021-01988-0

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：831 / 831

页数：1

共 50 条

[21] Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Chabi, A.
Baranak, C.
Lupinacci, R.
Herring, W. J.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (07) : 577 - 586
[22] Treatment of open angle glaucoma or ocular hypertension with preservative-free tafluprost/timolol fixed dose combination in a real-world setting: analysis by diagnostic sub-group at study entry
Oddone, Francesco
Saborio, Gabriela
Pavicic-Astalos, Jasna
Scorcia, Vincenzo
Moreno-Valladares, Antonio
Hollo, Gabor
ACTA OPHTHALMOLOGICA, 2022, 100
[23] Treatment of open angle glaucoma or ocular hypertension with preservative-free tafluprost/timolol fixed dose combination in a real-world clinical practice setting: a cross-country subanalysis
Oddone, Francesco
Fassari, Claudia
Iester, Michele
Lopez-Lopez, Fernando
Hollo, Gabor
ACTA OPHTHALMOLOGICA, 2022, 100
[24] Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension
Radell, J. E.
Serle, J. B.
DRUGS OF TODAY, 2019, 55 (09) : 563 - 574
[25] COMPARATIVE EFFECTIVENESS OF PEAK AND TROUGH EFFECTS OF BIMATOPROST 0.03%/TIMOLOL 0.5% PRESERVATIVE-FREE FIXED COMBINATION FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
Harvey, B.
Stradwick, S.
Brereton, N. J.
Shergill, S.
Wong, W.
VALUE IN HEALTH, 2013, 16 (07) : A502 - A502
[26] Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Suzuki, Katsuyoshi
Otsuka, Naomi
Hizaki, Hiroko
Hashimoto, Masayo
Kuwayama, Yasuaki
ADVANCES IN THERAPY, 2018, 35 (06) : 796 - 808
[27] Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Katsuyoshi Suzuki
Naomi Otsuka
Hiroko Hizaki
Masayo Hashimoto
Yasuaki Kuwayama
Advances in Therapy, 2018, 35 : 796 - 808
[28] Efficacy and safety of a new preservative-free fixed combination latanoprost-timolol (T2347) for open-angle glaucoma or ocular hypertension
Clarke, Jonathan C.
Lavin-Dapena, Cosme
Zarnowski, Tomasz
Pfeiffer, Norbert
Nordmann, Jean Philippe
Stalmans, Ingeborg
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[29] Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension (vol 35, pg 796, 2018)
Suzuki, Katsuyoshi
Otsuka, Naomi
Hizaki, Hiroko
Hashimoto, Masayo
Kuwayama, Yasuaki
ADVANCES IN THERAPY, 2019, 36 (02) : 492 - 494
[30] HEALTH ECONOMIC EVALUATION OF PRESERVATIVE-FREE TAFLUPROST VERSUS PRESERVED LATANOPROST IN THE TREATMENT OF OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION (OH)
Makino, K.
Charles, H.
Tilden, D.
Cottrell, S.
Mudge, M.
Christova, L.
Van Bavel, J.
West, B.
Woodgate, A. M.
VALUE IN HEALTH, 2012, 15 (07) : A643 - A643

← 1 2 3 4 5 →